Source: DealStreetAsia

JDRF: Temasek leads $65m Series D round in US-based SQZ Biotechnologies

The proceeds will be used to support the advancement of SQZ's cell therapy pipeline.The post Temasek leads $65m Series D round in US-based SQZ Biotechnologies appeared first on DealStreetAsia.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Aaron J. Kowalski's photo - President & CEO of JDRF

President & CEO

Aaron J. Kowalski

CEO Approval Rating

82/100

JDRF is a non-profit organization that researches and develops novel therapeutics for the treatment of diabetic diseases. Read more